GlassScriptPhysician profile
Nicholas S Adams
NPI 1396184859
$7,115.56
in general payments reported to CMS, 2019-2025
16 companies · $1,650 in 2025
The $1,650 reported for 2025 was more than what 82% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,662 · 2020: $212 · 2021: $1,514 · 2022: $227 · 2023: $367 · 2024: $483 · 2025: $1,650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $846 · Travel and Lodging: $766 · Food and Beverage: $562 · Long Term Medical Supply Or Device Loan: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $846.15 |
| Travel and Lodging | $766.33 |
| Food and Beverage | $561.99 |
| Long Term Medical Supply Or Device Loan | $325.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $2,508.72 | 2019 | |
| Sioux Surgical INC | $1,200.00 | 2021 | |
| Abbvie INC. | $1,172.15 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Motiva USA, LLC | $815.34 | 2025 | |
| Integra Lifesciences Corporation | $416.47 | 2020-2025 | Durasorb Monofilament Mesh |
| Allergan, INC. | $311.45 | 2020-2022 | |
| Galderma Laboratories, L.P. | $186.03 | 2021-2023 | |
| Mentor Worldwide LLC | $176.52 | 2020-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Derma Sciences, INC. | $153.47 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $56.65 | 2025 | |
| Heron Therapeutics, INC. | $34.40 | 2023 | Zynrelef |
| Endo Pharmaceuticals INC. | $22.66 | 2021 | |
| Antares Pharma, INC. | $16.87 | 2020 | |
| Acadia Pharmaceuticals INC | $16.68 | 2020 | |
| Omeros Corporation | $16.18 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $11.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.